IP Library Granted Patent US 8,261,749
Granted Patent B2
US 8,261,749 · App. 12/194,316 · Granted Sep 11, 2012

Augmentation and repair of vocal cord tissue defects

Assignee: Fibrocell Science, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,261,749
App. No.
12/194,316
Granted
Sep 11, 2012
Kind
B2
Abstract

A method for corrective surgery in a human subject of a vocal cord defect amenable to rectification by the augmentation of tissue subadjacent to the vocal cord defect, the method comprising: injecting an effective amount of autologous in vitro cultured fibroblast cells into the lamina propia, Reinke's space, the lateral tissue or the lateral edge of the vocal cord tissue of the subject in a position subadjacent to the vocal cord defect, wherein the in vitro fibroblast cultured cells are retrieved from the subject.

Claims (6)

1. A method for corrective surgery in a human subject of a vocal cord defect amenable to rectification by the augmentation of tissue subadjacent to the vocal cord defect, the method comprising:

injecting an effective amount of autologous in vitro cultured fibroblast cells into the lamina propria, Reinke's space, the lateral tissue or the lateral edge of the vocal cord tissue of the subject in a position subadjacent to the vocal cord defect,

wherein the in vitro fibroblast cultured cells are obtained by culturing a plurality of viable cells retrieved from the subject.

2. The method of claim 1 wherein the fibroblasts are derived from a tissue selected from the group consisting of dermis, fascia, connective tissue, and lamina propria.

3. The method of claim 1 wherein serum from the subject is used for the in vitro culture of cells.

4. The method of claim 1 wherein the in vitro cultured cells are washed in phosphate buffered saline before being placed into the tissue of the subject.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: FIBROCELL TECHNOLOGIES, INC.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 055641/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: FIBROCELL SCIENCE, INC.
To: CASTLE CREEK BIOSCIENCES, LLC
Reel/Frame 055642/0372 →
CHANGE OF NAME Recorded Aug 24, 2011
From: ISOLAGEN TECHNOLOGIES, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 026803/0103 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERROR IN ASSIGNEE NAME WHICH IS ISOLAGEN TECHNOLOGIES, INC.; NOW D/B/A FIBROCELL TECHNOLOGIES, INC. PREVIOUSLY RECORDED ON REEL 026709 FRAME 0354. ASSIGNOR(S) HEREBY CONFIRMS THE ENTIRE RIGHT, TITLE AND INTEREST IN THE INVENTIONS WAS TRANSFERRED BY GREGORY S. KELLER TO ASSIGNEE. Recorded Aug 24, 2011
From: KELLER, GREGORY S.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 026803/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2011
From: KELLER, GREGORY S.
To: ISOLAGEN, INC.
Reel/Frame 026709/0354 →
CHANGE OF NAME Recorded Jul 15, 2011
From: ISOLAGEN, INC.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 026601/0287 →
Continuity (4)
Continuation 09634038 · Aug 8, 2000
Division 09003378 · Jan 6, 1998
Provisional Application 60037961 · Feb 20, 1997
Related Publication 20080311089A1 · Dec 18, 2008